Ad
related to: BioNTech and Vaccine- View Meningitis Vaccines
Learn More About Vaccines And
Explore The Meningitis Portfolio
- Meningitis Portfolio
View Resources & Product Portfolio
Learn About The Vaccine Portfolio
- GSK Meningitis Portfolio
Explore GSK Meningitis Vaccines And
Learn About The Vaccine Portfolio
- GSK Portfolio
Learn More About Vaccines And
Explore The Science Behind GSK
- View Meningitis Vaccines
Search results
Research identifies an infectious language epidemic
Digital Journal· 5 days agoWhat effects did social media rhetoric have on COVID-19 infection and death rates across the U.S., and what can policymakers and public health officials...
Bird Flu Keeps Spreading in U.S. Cows. 5 Big Questions, Answered.
Barrons.com· 3 days agoThe CDC said this week that O’Connell’s agency is planning more studies to begin late this summer....
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 1 day agoCAR-T drugs are developed using a patient's own immune cells. Promisingly, Pfizer said in February...
Explainer-What are the FLiRT COVID variants and are they more contagious? By Reuters
Investing.com· 7 days agoThe moniker FLiRT is an acronym for the locations of the mutations the variants share on the virus'...
How to Protect the World from the Next Pandemic | by Winnie Byanyima & Joseph E. Stiglitz - Project...
Project Syndicate· 1 day agoNEW YORK – “History teaches us that the next pandemic is a matter of when, not if,” warned World...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 6 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
‘Cloaked’ proteins deliver cancer-killing therapeutics into cells | Cornell Chronicle
Cornell News Service· 3 days agoAn interdisciplinary collaboration has designed a way to “cloak” proteins so that they can be...
New approach uses 'cloaked' proteins to deliver cancer-killing therapeutics into cells
Phys.org· 2 days agoThe generalizable technique could lead to repurposing thousands of commercial protein products, including antibodies, for biological research and therapeutic applications. The group's paper, ...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Director-General’s Award for Global Health goes to Prime Minister of Barbados and developers of mRNA...
World Health Organization· 3 days agoWHO Director-General Dr Tedros Adhanom Ghebreyesus presented his Award for Global Health to the...